Active-fixation left ventricular leads integrated with epicardial ablation provide an effective strategy for managing malignant arrhythmias in pediatric LMNA-mutation carriers.
Does active-fixation CRT-D integrated with epicardial ablation improve management of malignant arrhythmias in pediatric LMNA-mutation carriers?
A dual-track strategy utilizing active-fixation CRT-D and epicardial ablation offers a stable and effective approach for managing malignant arrhythmias in pediatric patients with LMNA-related cardiomyopathy.
Absolute Event Rate: 0% vs 0%
Active-fixation LV leads, integrated with epicardial ablation, provide a stable and effective "dual-track" strategy for managing malignant arrhythmias in pediatric LMNA-mutation carriers.
Wang et al. (Wed,) reported a other. Active-fixation left ventricular leads integrated with epicardial ablation provide an effective strategy for managing malignant arrhythmias in pediatric LMNA-mutation carriers.